Copyright: ©Author(s) 2026.
World J Clin Oncol. Apr 24, 2026; 17(4): 119365
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.119365
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.119365
Table 2 Diagnostic value of carcinoembryonic antigen, cytokeratin 19 fragment, neuron-specific enolase, interleukin-8, monocyte chemoattractant protein-1, and tumor necrosis factor-alpha
| Indicator | AUC (95%CI) | P value | Cut-off value | Sensitivity (%) | Specificity (%) |
| CEA | 0.755 (0.694-0.816) | < 0.001 | 2.85 | 72.6 | 81.1 |
| CY211 | 0.703 (0.639-0.767) | < 0.001 | 2.26 | 68.1 | 74.8 |
| NSE | 0.587 (0.514-0.661) | 0.017 | 10.10 | 56.6 | 67.1 |
| IL-8 | 0.957 (0.935-0.978) | < 0.001 | 126.25 | 93.8 | 94.4 |
| MCP-1 | 0.825 (0.772-0.877) | < 0.001 | 427.64 | 86.7 | 88.1 |
| TNF-α | 0.936 (0.907-0.965) | < 0.001 | 9.85 | 89.4 | 90.9 |
- Citation: Zhang YN, Jiang T, Zhang PJ, Wang HJ. Construction and validation of a multiparameter diagnostic model based on conventional tumor markers and cytokines for lung cancer. World J Clin Oncol 2026; 17(4): 119365
- URL: https://www.wjgnet.com/2218-4333/full/v17/i4/119365.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i4.119365